Follow Us TR

News Details

Fortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University to Develop Novel Oligonucleotide Platform for the Treatment of Genetically Driven Cancers

About Fortress Biotech, Inc.
  • NASDAQ: $FBIO
  • Notified: $2.75
  • 07:30 EDT

Price Chart